2020
DOI: 10.22159/ijcpr.2020v12i5.39755
|View full text |Cite
|
Sign up to set email alerts
|

Outbreak, Epidemiology, Therapeutics and Prevention of Coronavirus Disease-2019: A Review

Abstract: The outbreak of pneumonia of unknown cause during December 2019 was reported from Wuhan City, Hubei province capital in China as its epicenter. Symptoms of pneumonia in several patients admitted to hospitals from Wuhan, China during December 2019. The sudden increase in the patients having the same symptoms, in due course the contributing means was isolated from the infected populace. In the present short report, we have summarized various public health measures, viz., early marking of the suspected patient, d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 22 publications
0
4
0
Order By: Relevance
“…It became apparent that the distribution of vaccines was discriminatory depending on the participants' gender, with females predominantly receiving the Sinopharm vaccine while males receiving mostly Pfizer. The age group also played a significant role, with older individuals (above 60) more likely to receive the Oxford-AstraZeneca vaccine, while the younger aged group (11)(12)(13)(14)(15)(16)(17)(18)(19)(20) received Pfizer or Sinopharm vaccines. Previous research found that individuals with a non-overweight status had a higher risk of presenting fever ≥ 38 °C, vomiting, diarrhea, and chills after receiving the COVID-19 vaccine compared to those who were overweight, although most reported side effects were not significantly associated with weight status, and individual differences were determined by sex and age [25].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It became apparent that the distribution of vaccines was discriminatory depending on the participants' gender, with females predominantly receiving the Sinopharm vaccine while males receiving mostly Pfizer. The age group also played a significant role, with older individuals (above 60) more likely to receive the Oxford-AstraZeneca vaccine, while the younger aged group (11)(12)(13)(14)(15)(16)(17)(18)(19)(20) received Pfizer or Sinopharm vaccines. Previous research found that individuals with a non-overweight status had a higher risk of presenting fever ≥ 38 °C, vomiting, diarrhea, and chills after receiving the COVID-19 vaccine compared to those who were overweight, although most reported side effects were not significantly associated with weight status, and individual differences were determined by sex and age [25].…”
Section: Discussionmentioning
confidence: 99%
“…After publishing the genome sequence of SARS-CoV-2 on 11 January 2020, vaccine development was initiated globally and the first vaccine started the first human clinical trial on 16 th March 2020 [5,9]. As SARS-CoV-2 bind with the host cell receptor ACE-2 (angiotensinconverting enzyme 2) through its spike (S) protein to enter the host cell, most vaccine targeted with neutralizing antibodies against S protein thus prevent binding with ACE-2 receptor and pathogenesis of virus [12]. The first approved vaccine was developed by Pfizer/BioNTech (Dec 2020) and accepted in 146 countries [13,14].…”
Section: Introductionmentioning
confidence: 99%
“…The novel coronavirus, SARS-CoV-2 belonged to beta-coronavirus class, family Coronaviridae and order Nidovirales [1,2]. SARS-CoV-2 has been hypothesized to originate from bat CoV, RaTG13 (96% whole genome level).…”
Section: Introductionmentioning
confidence: 99%
“…Suffices to say, the COVID-19 virus has a very expeditious spreadability, and due to its contagious nature, influenza-related mortality is seen [11]. Evidence suggests that Diabetic patients tend to observe symptoms of either severe acute respiratory syndrome (SARS) or Middle East Respiratory Syndrome (MERS) but definitely not limited to the traditional symptoms observed [12,13]. Such cases have been seen in India.…”
Section: Introductionmentioning
confidence: 99%